Annual CAPEX
N/A
December 31, 2023
Summary
- AKBA annual capital expenditures is not available.
Performance
AKBA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
$2000.00
-$27.00 K-93.10%
September 30, 2024
Summary
- As of February 8, 2025, AKBA quarterly capital expenditures is $2000.00, with the most recent change of -$27.00 thousand (-93.10%) on September 30, 2024.
- Over the past year, AKBA quarterly CAPEX has dropped by -$27.00 thousand (-93.10%).
- AKBA quarterly CAPEX is now -99.92% below its all-time high of $2.53 million, reached on September 30, 2019.
Performance
AKBA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$31.00 K
+$2000.00+6.90%
September 30, 2024
Summary
- As of February 8, 2025, AKBA TTM capital expenditures is $31.00 thousand, with the most recent change of +$2000.00 (+6.90%) on September 30, 2024.
- Over the past year, AKBA TTM CAPEX has increased by +$2000.00 (+6.90%).
- AKBA TTM CAPEX is now -99.57% below its all-time high of $7.26 million, reached on September 30, 2019.
Performance
AKBA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
AKBA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -93.1% | +6.9% |
| 3 y3 years | - | +100.0% | -47.5% |
| 5 y5 years | - | +100.0% | -47.5% |
AKBA CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.3% | -100.0% | -72.8% | +6.9% | ||
| 5 y | 5-year | -99.4% | +104.4% | -99.5% | +6.9% | ||
| alltime | all time | -99.9% | +104.4% | -99.6% | +6.9% |
Akebia Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2000.00(-93.1%) | $31.00 K(+6.9%) |
| Jun 2024 | - | $29.00 K(>+9900.0%) | $29.00 K(-74.6%) |
| Dec 2022 | $114.00 K(+93.2%) | $0.00(0.0%) | $114.00 K(0.0%) |
| Sep 2022 | - | $0.00(0.0%) | $114.00 K(0.0%) |
| Jun 2022 | - | $0.00(-100.0%) | $114.00 K(0.0%) |
| Mar 2022 | - | $114.00 K(>+9900.0%) | $114.00 K(+93.2%) |
| Dec 2021 | $59.00 K(-81.4%) | $0.00(0.0%) | $59.00 K(-84.3%) |
| Sep 2021 | - | $0.00(0.0%) | $376.00 K(+13.6%) |
| Jun 2021 | - | $0.00(-100.0%) | $331.00 K(-12.0%) |
| Mar 2021 | - | $59.00 K(-81.4%) | $376.00 K(+18.6%) |
| Dec 2020 | $317.00 K(-95.2%) | $317.00 K(-804.4%) | $317.00 K(+44.1%) |
| Sep 2020 | - | -$45.00 K(-200.0%) | $220.00 K(-92.1%) |
| Jun 2020 | - | $45.00 K(-79.5%) | $2.79 M(-58.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $6.66 M(+314.4%) | $220.00 K(-91.3%) | $6.66 M(-8.4%) |
| Sep 2019 | - | $2.53 M(+27.9%) | $7.26 M(+44.1%) |
| Jun 2019 | - | $1.98 M(+2.6%) | $5.04 M(+55.7%) |
| Mar 2019 | - | $1.93 M(+132.3%) | $3.24 M(+101.6%) |
| Dec 2018 | $1.61 M(-1.0%) | $830.00 K(+170.4%) | $1.61 M(+31.0%) |
| Sep 2018 | - | $307.00 K(+77.5%) | $1.23 M(-19.1%) |
| Jun 2018 | - | $173.00 K(-41.6%) | $1.52 M(+1.7%) |
| Mar 2018 | - | $296.00 K(-34.2%) | $1.49 M(-8.1%) |
| Dec 2017 | $1.62 M(-39.1%) | $450.00 K(-24.6%) | $1.62 M(+33.0%) |
| Sep 2017 | - | $597.00 K(+303.4%) | $1.22 M(+95.8%) |
| Jun 2017 | - | $148.00 K(-65.3%) | $623.00 K(+31.2%) |
| Mar 2017 | - | $427.00 K(+789.6%) | $475.00 K(+889.6%) |
| Dec 2016 | $2.66 M | $48.00 K | $48.00 K |
FAQ
- What is the all time high annual CAPEX for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly CAPEX year-on-year change?
- What is Akebia Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Akebia Therapeutics?
- What is Akebia Therapeutics TTM CAPEX year-on-year change?
What is the all time high annual CAPEX for Akebia Therapeutics?
Akebia Therapeutics all-time high annual capital expenditures is $6.66 M
What is Akebia Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of AKBA is $2000.00
What is the all time high quarterly CAPEX for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly capital expenditures is $2.53 M
What is Akebia Therapeutics quarterly CAPEX year-on-year change?
Over the past year, AKBA quarterly capital expenditures has changed by -$27.00 K (-93.10%)
What is Akebia Therapeutics TTM capital expenditures?
The current TTM CAPEX of AKBA is $31.00 K
What is the all time high TTM CAPEX for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM capital expenditures is $7.26 M
What is Akebia Therapeutics TTM CAPEX year-on-year change?
Over the past year, AKBA TTM capital expenditures has changed by +$2000.00 (+6.90%)